RNXT
Income statement / Annual
Last year (2024), RenovoRx, Inc.'s total revenue was $43,000.00,
and the percentage change from the previous year is not available.
In 2024, RenovoRx, Inc.'s net income was -$8.81 M.
See RenovoRx, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$43,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$6,000.00
|
$9,000.00
|
$0.00
|
$0.00
|
| Gross Profit |
$43,000.00
|
$0.00
|
-$6,000.00
|
-$9,000.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
1
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$6.03 M
|
$5.67 M
|
$4.30 M
|
$3.04 M
|
$2.39 M
|
$3.00 M
|
| General & Administrative Expenses |
$4.99 M
|
$5.73 M
|
$5.65 M
|
$2.63 M
|
$818,000.00
|
$899,000.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$4.99 M
|
$5.73 M
|
$5.65 M
|
$2.63 M
|
$818,000.00
|
$899,000.00
|
| Other Expenses |
$0.00
|
$0.00
|
$61,000.00
|
$119,000.00
|
-$7,000.00
|
$2,000.00
|
| Operating Expenses |
$11.01 M
|
$11.40 M
|
$9.95 M
|
$5.67 M
|
$3.20 M
|
$3.90 M
|
| Cost And Expenses |
$11.01 M
|
$11.40 M
|
$9.95 M
|
$5.67 M
|
$3.20 M
|
$3.90 M
|
| Interest Income |
$0.00
|
$0.00
|
$57,000.00
|
$0.00
|
$3,000.00
|
$63,000.00
|
| Interest Expense |
$0.00
|
$108,000.00
|
$57,000.00
|
$834,000.00
|
$590,000.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$6,000.00
|
$6,000.00
|
$9,000.00
|
$3.20 M
|
$3.90 M
|
| EBITDA |
-$10.97 M |
-$11.39 M |
-$9.94 M |
-$5.66 M |
$0.00 |
$0.00 |
| EBITDA Ratio |
-255.12
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-255.12
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$2.16 M
|
$1.16 M
|
$61,000.00
|
-$653,000.00
|
-$594,000.00
|
$57,000.00
|
| Income Before Tax |
-$8.81 M
|
-$10.23 M
|
-$9.89 M
|
-$6.32 M
|
-$3.80 M
|
-$3.84 M
|
| Income Before Tax Ratio |
-204.98
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$118,000.00
|
$772,000.00
|
$587,000.00
|
-$63,000.00
|
| Net Income |
-$8.81 M
|
-$10.23 M
|
-$9.77 M
|
-$7.10 M
|
-$4.39 M
|
-$3.78 M
|
| Net Income Ratio |
-204.98
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.4 |
-0.5 |
-0.54 |
-0.4 |
-0.25 |
-0.22 |
| EPS Diluted |
-0.4 |
-0.5 |
-0.54 |
-0.4 |
-0.25 |
-0.22 |
| Weighted Average Shares Out |
$22.27 M
|
$20.58 M
|
$18.10 M
|
$17.87 M
|
$17.32 M
|
$17.32 M
|
| Weighted Average Shares Out Diluted |
$22.27 M
|
$20.58 M
|
$18.10 M
|
$17.87 M
|
$17.32 M
|
$17.32 M
|
| Link |
|
|
|
|
|
|
